AJP - Heart AJP: Lung Cellular and Molecular Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 277: H2381-H2391, 1999;
0363-6135/99 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sumbilla, C.
Right arrow Articles by Inesi, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sumbilla, C.
Right arrow Articles by Inesi, G.
Vol. 277, Issue 6, H2381-H2391, December 1999

Comparison of SERCA1 and SERCA2a expressed in COS-1 cells and cardiac myocytes

Carlota Sumbilla, Marco Cavagna, Lilin Zhong, Hailun Ma, David Lewis, Iain Farrance, and Giuseppe Inesi

Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland 21201

Cultured COS-1 cells, as well as chicken embryonic and neonatal rat cardiac myocytes, were infected with recombinant adenovirus vectors to define limiting factors in the expression and Ca2+ transport function of recombinant sarcoplasmic-endoplasmic reticulum Ca2+ (SERCA) isoforms. Titration experiments showed that all COS-1 cells and myocytes in culture could be infected by an adenovirus titer of 10 plaque-forming units (pfu) per seeded cell. Raising the adenovirus titer further yielded higher protein expression up to an asymptotic limit for functional, membrane-bound SERCA protein. The asymptotic behavior of SERCA expression was not transcription related but was due to posttranscriptional events. The minimal (-268) cardiac troponin T (cTnT) promoter was a convenient size for adenovirus vector construction and manifested tight muscle specificity. However, its efficiency was lower than that of the nonspecific cytomegalovirus (CMV) promoter. At any rate, identical maximal levels of SERCA expression were obtained with the CMV and the cTnT promoter, as long as the viral titer was adjusted to compensate for transcription efficiency. A maximal threefold increase of total SERCA protein expression over the level of the endogenous SERCA of control myocytes was reached (a sevenfold increase compared with the endogenous SERCA of the same infected myocytes due to reduction of endogenous SERCA after infection). In contrast with previous reports [Ji et al. Am. J. Physiol. 276 (Heart Circ. Physiol. 45): H89-H97, 1999], a higher kinetic turnover was demonstrated for the SERCA1 compared with the SERCA2a isoform as shown by a 5.0- versus 2.6-fold increase in calcium uptake rate accompanying maximal expression of recombinant SERCA1 or SERCA2a, respectively. This information is deemed necessary for studies attempting to modify myocardial cell function by manipulation of SERCA expression.

calcium adenosine 5'-triphosphatase; sarcoplasmic-endoplasmic reticulum calcium; adenovirus vectors


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
A. M. Prasad and G. Inesi
Effects of thapsigargin and phenylephrine on calcineurin and protein kinase C signaling functions in cardiac myocytes
Am J Physiol Cell Physiol, May 1, 2009; 296(5): C992 - C1002.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. M. O'Donnell, A. Fields, X. Xu, S. A. K. Chowdhury, D. L. Geenen, and J. Bi
Limited functional and metabolic improvements in hypertrophic and healthy rat heart overexpressing the skeletal muscle isoform of SERCA1 by adenoviral gene transfer in vivo
Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2483 - H2494.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
G. Smith
Matters of the heart: the physiology of cardiac function and failure
Exp Physiol, November 1, 2007; 92(6): 973 - 986.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. A. H. Talukder, A. Kalyanasundaram, X. Zhao, L. Zuo, P. Bhupathy, G. J. Babu, A. J. Cardounel, M. Periasamy, and J. L. Zweier
Expression of SERCA isoform with faster Ca2+ transport properties improves postischemic cardiac function and Ca2+ handling and decreases myocardial infarction
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2418 - H2428.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. M. Prasad, H. Ma, C. Sumbilla, D. I. Lee, M. G. Klein, and G. Inesi
Phenylephrine hypertrophy, Ca2+-ATPase (SERCA2), and Ca2+ signaling in neonatal rat cardiac myocytes
Am J Physiol Cell Physiol, June 1, 2007; 292(6): C2269 - C2275.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Hiranandani, T. Bupha-Intr, and P. M. L. Janssen
SERCA overexpression reduces hydroxyl radical injury in murine myocardium
Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H3130 - H3135.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Suarez, B. Gloss, D. D. Belke, Y. Hu, B. Scott, T. Dieterle, Y.-K. Kim, M. L. Valencik, J. A. McDonald, and W. H. Dillmann
Doxycycline inducible expression of SERCA2a improves calcium handling and reverts cardiac dysfunction in pressure overload-induced cardiac hypertrophy
Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2164 - H2172.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. Ma, C. M. Sumbilla, I. K. G. Farrance, M. G. Klein, and G. Inesi
Cell-specific expression of SERCA, the exogenous Ca2+ transport ATPase, in cardiac myocytes
Am J Physiol Cell Physiol, March 1, 2004; 286(3): C556 - C564.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Huke, V. Prasad, M. L. Nieman, K. J. Nattamai, I. L. Grupp, J. N. Lorenz, and M. Periasamy
Altered dose response to beta -agonists in SERCA1a-expressing hearts ex vivo and in vivo
Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H958 - H965.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. del Monte, R. J. Hajjar, S. E. Harding, and G. Inesi
Overwhelming Evidence of the Beneficial Effects of SERCA Gene Transfer in Heart Failure Response
Circ. Res., June 8, 2001; 88 (11): e66 - e67.
[Full Text] [PDF]


Home page
Circ. Res.Home page
M. Periasamy
Adenoviral-Mediated SERCA Gene Transfer Into Cardiac Myocytes : How Much Is Too Much?
Circ. Res., March 2, 2001; 88(4): 373 - 375.
[Full Text] [PDF]


Home page
Circ. Res.Home page
J. M. O'Donnell, C. M. Sumbilla, H. Ma, I. K. G. Farrance, M. Cavagna, M. G. Klein, and G. Inesi
Tight Control of Exogenous SERCA Expression Is Required to Obtain Acceleration of Calcium Transients With Minimal Cytotoxic Effects in Cardiac Myocytes
Circ. Res., March 2, 2001; 88(4): 415 - 421.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Jane Lalli, J. Yong, V. Prasad, K. Hashimoto, D. Plank, G. J. Babu, D. Kirkpatrick, R. A. Walsh, M. Sussman, A. Yatani, et al.
Sarcoplasmic Reticulum Ca2+ ATPase (SERCA) 1a Structurally Substitutes for SERCA2a in the Cardiac Sarcoplasmic Reticulum and Increases Cardiac Ca2+ Handling Capacity
Circ. Res., July 20, 2001; 89(2): 160 - 167.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online